These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21762914)
1. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Descamps OS; Tenoutasse S; Stephenne X; Gies I; Beauloye V; Lebrethon MC; De Beaufort C; De Waele K; Scheen A; Rietzschel E; Mangano A; Panier JP; Ducobu J; Langlois M; Balligand JL; Legat P; Blaton V; Muls E; Van Gaal L; Sokal E; Rooman R; Carpentier Y; De Backer G; Heller FR Atherosclerosis; 2011 Oct; 218(2):272-80. PubMed ID: 21762914 [TBL] [Abstract][Full Text] [Related]
2. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers. Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147 [TBL] [Abstract][Full Text] [Related]
3. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population. Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document]. Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F Semergen; 2015; 41(1):24-33. PubMed ID: 25042971 [TBL] [Abstract][Full Text] [Related]
5. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy. Vishwanath R; Hemphill LC J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children. Ose L Semin Vasc Med; 2004 Feb; 4(1):51-7. PubMed ID: 15199433 [TBL] [Abstract][Full Text] [Related]
7. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia. Khan SP; Ghani R; Ahmed KZ; Yaqoob Z J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527 [TBL] [Abstract][Full Text] [Related]
8. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia. Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849 [TBL] [Abstract][Full Text] [Related]
9. The detection of heterozygous familial hypercholesterolemia in Ireland. O'Kane MJ; Menown IB; Graham I; Maher V; Tomkin G; Nicholls P; Graham C Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724 [TBL] [Abstract][Full Text] [Related]
10. Guidelines for the management of familial hypercholesterolemia. Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242 [TBL] [Abstract][Full Text] [Related]
11. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
13. Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey. Block RC; Bang M; Peterson A; Wong ND; Karalis DG J Clin Lipidol; 2021; 15(5):682-689. PubMed ID: 34593357 [TBL] [Abstract][Full Text] [Related]
14. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Santos PC; Morgan AC; Jannes CE; Turolla L; Krieger JE; Santos RD; Pereira AC Atherosclerosis; 2014 Mar; 233(1):206-10. PubMed ID: 24529145 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease. Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426 [TBL] [Abstract][Full Text] [Related]
16. Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects. Béliard S; Carreau V; Carrié A; Giral P; Duchêne E; Farnier M; Ferrières J; Fredenrich A; Krempf M; Luc G; Moulin P; Bruckert E Atherosclerosis; 2014 May; 234(1):136-41. PubMed ID: 24637413 [TBL] [Abstract][Full Text] [Related]